Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1986-01-02
1988-03-01
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530324, 530402, A61K 3702, C07K 710
Patent
active
047286393
ABSTRACT:
A polypeptide having the formula Asn-Phe-Ser-Thr-Ala-Asp-Ser-Ala-Lys-Ile-Lys-Thr-Leu-Glu-Ala-Glu-Lys-Ala-Al a-Leu-Ala-Ala-Arg-Lys-Ala-Asp-Leu-Glu-Lys-Ala-Leu-Glu-Gly-Ala-Met is conjugated to polylysine.
REFERENCES:
patent: 4597967 (1986-07-01), Beachey
Phillips Delbert R.
University of Tennessee Research Corporation
LandOfFree
Type-specific opsonic antibodies evoked with a synthetic peptide does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Type-specific opsonic antibodies evoked with a synthetic peptide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Type-specific opsonic antibodies evoked with a synthetic peptide will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-997961